Tuesday, July 16, 2024 | Baltimore, MD

Maryland company would get big boost from FDA’s Narcan decision

February 17, 2023

Gaithersburg, Maryland-based biotech Emergent BioSolutions stands to gain from a Food and Drug Administration decision to make opioid overdose drug Narcan available without a prescription. It makes the nasal spray version of the opioid-overdose antidote naloxone. An FDA advisory panel this week recommended over-the-counter availability of Narcan. While the FDA is not required to follow any recommendations from advisory panels, it usually does.

Article Source: WTOP News

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.